Switch From Oral Therapy to Long-acting Injectable Cabotegravir + Rilpivirine
Switch From Oral Therapy to Long-acting Injectable Cabotegravir + Rilpivirine
Not yet recruiting · NCT05835635 · Registry updated 2024-11-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Switch From Oral Therapy to Long-acting Injectable Cabotegravir + Rilpivirine | Acceptability of Health Care; Patient Preference; Patient Satisfaction; Quality of Life | Not yet recruiting | Not stated | 2024-11-07 | NCT05835635 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pontificia Universidad Catolica de Chile | 49 |
| ViiV Healthcare | 53 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CICUC | Santiago | Chile | 1 |